- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
57
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
57 companies
Xiamen Amoytop Biotech
Market Cap: CN¥31.4b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥77.25
7D
3.6%
1Y
41.4%
SK Biopharmaceuticals
Market Cap: ₩7.3t
A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.
A326030
₩91,000.00
7D
0.6%
1Y
6.1%
Laboratorios Farmaceuticos Rovi
Market Cap: €2.8b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€54.45
7D
4.4%
1Y
-38.6%
Zhejiang Jolly PharmaceuticalLTD
Market Cap: CN¥11.1b
Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.
300181
CN¥16.04
7D
2.1%
1Y
3.2%
Hypera
Market Cap: R$16.0b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$25.40
7D
0.9%
1Y
-11.2%
Sotera Health
Market Cap: US$3.5b
Provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$12.24
7D
0.7%
1Y
6.8%
Vertex Pharmaceuticals
Market Cap: US$113.5b
A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).
VRTX
US$442.05
7D
1.4%
1Y
-6.0%
Akeso
Market Cap: HK$75.2b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$75.00
7D
-7.9%
1Y
70.5%
Suzhou Zelgen BiopharmaceuticalsLtd
Market Cap: CN¥28.8b
Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
688266
CN¥108.76
7D
16.0%
1Y
99.2%
Tonghua Dongbao Pharmaceutical
Market Cap: CN¥15.2b
Researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China.
600867
CN¥7.81
7D
1.2%
1Y
-14.9%
Almirall
Market Cap: €2.4b
Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.
ALM
€11.16
7D
3.0%
1Y
14.2%
Shanghai OPM Biosciences
Market Cap: CN¥4.9b
Provides cell culture media and CDMO services in China and internationally.
688293
CN¥42.91
7D
4.4%
1Y
18.9%
Zhejiang Garden BiopharmaceuticalLtd
Market Cap: CN¥8.0b
Zhejiang Garden Biopharmaceutical Co.,Ltd.
300401
CN¥14.71
7D
-1.6%
1Y
24.3%
Bonesupport Holding
Market Cap: SEK 16.7b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 254.20
7D
-5.4%
1Y
3.2%
AcrobiosystemsLtd
Market Cap: CN¥6.3b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions.
301080
CN¥52.50
7D
0.9%
1Y
34.0%
GC Biopharma
Market Cap: ₩1.5t
A biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally.
A006280
₩127,100.00
7D
-1.7%
1Y
9.9%
BioLife Solutions
Market Cap: US$1.0b
Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.
BLFS
US$21.88
7D
0.5%
1Y
2.9%
Innovent Biologics
Market Cap: HK$102.2b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.
1801
HK$63.10
7D
11.6%
1Y
83.4%
MedinCell
Market Cap: €551.8m
A pharmaceutical company, develops long acting injectables in various therapeutic areas in France.
MEDCL
€16.69
7D
-0.6%
1Y
3.0%
Repligen
Market Cap: US$6.6b
A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.
RGEN
US$118.07
7D
-0.07%
1Y
-21.5%
AstraZeneca
Market Cap: UK£166.2b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£107.20
7D
2.7%
1Y
-13.2%
Sinocelltech Group
Market Cap: CN¥17.6b
A biotech company, engages in the research and development, and industrialization of recombinant proteins, monoclonal antibodies, and innovative vaccines in China.
688520
CN¥39.61
7D
1.0%
1Y
-10.3%
Galderma Group
Market Cap: CHF 25.6b
Operates as a dermatology company worldwide.
GALD
CHF 107.70
7D
3.1%
1Y
49.6%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$71.1b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$319.00
7D
1.1%
1Y
82.0%
Genscript Biotech
Market Cap: HK$27.9b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$12.46
7D
3.8%
1Y
51.4%
Biocon
Market Cap: ₹401.9b
Engages in the manufacture and sale of biotechnology products and research services in India, Brazil, Singapore, and internationally.
BIOCON
₹334.00
7D
0.5%
1Y
7.9%
RemeGen
Market Cap: HK$32.5b
A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.
9995
HK$47.70
7D
3.7%
1Y
100.0%
Eli Lilly
Market Cap: US$662.2b
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.
LLY
US$737.67
7D
3.4%
1Y
-11.3%
ArcticZymes Technologies
Market Cap: NOK 809.5m
A life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing in Norway, Germany, Lithuania, France, Italy, the United Kingdom, rest of Europe, the United States, and internationally.
AZT
NOK 15.85
7D
-5.1%
1Y
-39.4%
Orchid Pharma
Market Cap: ₹31.9b
A pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India.
ORCHPHARMA
₹660.15
7D
-10.9%
1Y
-33.8%
Fine Foods & Pharmaceuticals N.T.M
Market Cap: €180.7m
Fine Foods & Pharmaceuticals N.T.M. S.p.A.
FF
€7.38
7D
0.8%
1Y
-14.2%
Zhejiang Tianyu Pharmaceutical
Market Cap: CN¥7.8b
Engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally.
300702
CN¥22.67
7D
4.1%
1Y
18.1%
Navamedic
Market Cap: NOK 388.6m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
NAVA
NOK 22.00
7D
1.9%
1Y
-34.5%
CSPC Innovation Pharmaceutical
Market Cap: CN¥72.3b
Engages in the research and development, production, and sales of biopharmaceuticals, APIs, and functional foods in China and internationally.
300765
CN¥51.91
7D
6.7%
1Y
70.2%
Nanjing Vazyme Biotech
Market Cap: CN¥8.7b
Offers technology solutions for life science, biomedicine, and in vitro diagnostics.
688105
CN¥21.94
7D
2.8%
1Y
-0.9%
Yuhan
Market Cap: ₩7.8t
Manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally.
A000100
₩104,000.00
7D
-0.2%
1Y
38.7%